Partner Content Partner Content 2nd World Companion Diagnostics & Liquid Biopsy Summit APAC The Asia-Pacific region is becoming a rising player in the co-development and commercialization of drug-diagnostic strategies
Partner Content Partner Content 10th CAR-TCR Summit – A Decade of Engineering a Disease-Free... It's a pivotal moment for cell therapy. New trials, breakthrough data, major acquisitions and regulatory shifts are transforming the landscape...
Partner Content Partner Content LEAN Cell & Gene Summit Boston Manufacturing Advanced Therapies Just in Time for All Patients
Partner Content Partner Content 2nd Hit ID Summit Why prioritise your hit discovery game? Finding the right chemical start points is crucial to help you save time and costs in the long run.
R&D Partner Content Unlocking the Potential of Targeting the Innate Immune Syste... Ready to Catalyze the Next Wave of Inflammasome Therapies?
Partner Content Partner Content 5th Oligonucleotides for CNS Summit The Oligonucleotides for CNS Summit returns for its 5th year to address key challenges in durability, scalability, potency and CNS tropism
News Bayer reveals data behind asundexian's stroke win Bayer's oral Factor XIa inhibitor asundexian can reduce the risk of a secondary ischaemic stroke by 26%, according to the OCEANIC-STROKE trial.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.